Cargando…
Impact of Pretransplant Donor and Recipient Cytomegalovirus Serostatus on Outcome for Multiple Myeloma Patients Undergoing Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation
Scope of the study was to investigate the impact of pre-transplant CMV serostatus of the donor and/or recipient on the outcome of patients undergoing allogeneic hematopoietic stem cell transplantation (Allo-SCT) for Multiple Myeloma (MM). To our knowledge no data are available in the literature abou...
Autores principales: | El-Cheikh, Jean, Devillier, Raynier, Crocchiolo, Roberto, Fürst, Sabine, Calmels, Boris, Faucher, Catherine, Stoppa, Anne Marie, Granata, Angela, Castagna, Luca, Ladaique, Patrick, Lemarie, Claude, Bouabdallah, Reda, Zandotti, Christine, Merlin, Michele, Berger, Pierre, Chabannon, Christian, Blaise, Didier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3647712/ https://www.ncbi.nlm.nih.gov/pubmed/23667724 http://dx.doi.org/10.4084/MJHID.2013.026 |
Ejemplares similares
-
Comparison of Three Distinct Prophylactic Agents Against Invasive Fungal Infections in Patients Undergoing Haplo-identical Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
por: El-Cheikh, Jean, et al.
Publicado: (2015) -
Manufacturing Natural Killer Cells as Medicinal Products
por: Chabannon, Christian, et al.
Publicado: (2016) -
JC Virus Leuko-Encephalopathy in Reduced Intensity Conditioning Cord Blood Transplant Recipient with a Review of the Literature
por: El-Cheikh, Jean, et al.
Publicado: (2012) -
Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome
por: Castagna, Luca, et al.
Publicado: (2020) -
Related versus unrelated allogeneic HPC graft cryopreservation: a single-center experience in the context of the global COVID-19 pandemic
por: Mfarrej, B., et al.
Publicado: (2021)